Per J. Hellsund

President, Chief Executive Officer & Director at Cybrexa, Inc.

Per J. Hellsund

Per J. Hellsund

President, Chief Executive Officer & Director at Cybrexa, Inc.

Overview
Career Highlights

inc.jet, Inc.
Cybrexa, Inc.
CyVek, Inc.

RelSci Relationships

78

Number of Boards

2

Contact Data
Trying to get in touch with Per J. Hellsund? Subscribe today to access their professional contact information and receive a one time promotion of free Contact Data credits!
Relationships
RelSci Relationships are individuals Per J. Hellsund likely has professional access to. A relationship does not necessarily indicate a personal connection.

Executive Chairman at Aziyo Biologics, Inc.

Relationship likelihood: Strong

President, Chief Executive Officer & Founder at CiDRA Corporate Services, Inc.

Relationship likelihood: Strong

Chief Scientific Officer at Cybrexa, Inc.

Relationship likelihood: Strong

Co-Founder & Investor at LinkedAge LLC

Relationship likelihood: Strong

Executive Vice President & Chief Investment Officer at Connecticut Innovations, Inc.

Relationship likelihood: Strong

President & Chief Executive Officer at Arvinas, Inc.

Relationship likelihood: Strong

Chief of Medical Oncology at Yale Cancer Center

Relationship likelihood: Strong

Chief of Therapeutic Radiology at Yale-New Haven Hospital, Inc.

Relationship likelihood: Strong

President & Chief Executive Officer at Gunther International Ltd.

Relationship likelihood: Strong

Former President, Chief Executive Officer & Director at Bio-Techne Corp.

Relationship likelihood: Strong

Paths to Per J. Hellsund
Potential Connections via
Relationship Science
You
Per J. Hellsund
President, Chief Executive Officer & Director at Cybrexa, Inc.
Education
MS Management

Rensselaer Polytechnic Institute, or RPI, is a private research university located in Troy, New York, with two additional campuses in Hartford and Groton, Connecticut. It was founded in 1824 by Stephen van Rensselaer and Amos Eaton for the "application of science to the common purposes of life" and is the oldest technological university in the English-speaking world.

Career History
President, Chief Executive Officer & Director
2016 - Current

Cybrexa, Inc. develops molecule DNA repair inhibitors that directly target the tumor microenvironment. It develops and commercializes technologies that enables to improve cancer therapeutics. The company was founded by Per J. Hellsund, F. Kevin Didden, Ranjit S. Bindra, and Peter Glazer in 2016 and is headquartered in New Haven, CT.

Founder
2010 - Prior

CyVek, Inc. engages in the development of a novel, platform technology for measuring analytes in biological samples. It is a biotechnology company dedicated to the advancement of healthcare by empowering researchers and clinicians with a disruptive technology for performing multi-analyte immunoassays. The firm is a versatile platform that can be quickly and easily configured for diverse applications such as rapid diagnostic tests, multi-sample multi-analyte tests, or routine ELISA-like tests, for use in both research and clinical settings. The company offers an breadth of applications, from life science research to drug discovery, personalized medicine, diagnostics, and point-of-care testing. CyVek was founded by Per J. Hellsund, Rajiv Pandey and Marty Andrew Putnam in 2010 and is headquartered in Wallingford, CT.

President
Prior

inc.jet, Inc. supplies rugged and effective printing solutions. It develops variable data printing equipment and solutions for the mail, graphics and packaging markets. The company was founded in 1998 and is headquartered in Norwich, CT.

Non-Profit Donations & Grants

Learn how non-profit organizations benefit from RelSci
$100 - $249
2012

Yale-New Haven Hospital, Inc. provides health care services and medical courses. The firm’s clinical programs and services include advanced vascular imaging services, allergy and immunology, ambulatory services, bariatric surgery program, cardiac rehabilitation, dental services, dermatology services, diabetes and endocrinology, ear, nose & throat (otolaryngology), electrophysiology and cardiac arrhythmia service and interventional cardiology. The company was founded in 1826 and is headquartered in New Haven, CT.

$250 - $499
2011

Beth Israel Deaconess Medical Center (BIDMC) is one of the nation's preeminent academic medical centers. We are committed to excellence in clinical care, biomedical research and education and to the health and wellness of our patients and our communities. Excellence In Clinical Care Beth Israel Deaconess, a major teaching hospital of Harvard Medical School, is a fully integrated medical center providing adult services from cardiology to obstetrics, gastrointestinal disorders to cancer care. Each year U.S. News & World Report ranks BIDMC as a "Best Hospital" in multiple specialties. As national leaders in patient care quality, safety and transparency, we are setting standards in the way health data can be used to improve care and services. We were the first hospital in the country to achieve meaningful use of electronic medical records, meeting a key set of new federal government standards. BIDMC attracts leading clinicians in all medical fields. Our experts not only provide gold standard treatments to help a patient get better, they also help educate the public on disease prevention. BIDMC clinicians feel a responsibility to do more than make patients better when they are sick-they want to help the community stay healthy. Excellence In Research BIDMC is home to a renowned academic research program, where scientific discoveries help to transform medical care. We rank third in the country for National Institutes of Health funding among independent hospitals. With revolutionary advances and therapies happening within our walls, we are a national and international leader in "bench-to-bedside" research. Our patients benefit directly from our dedication to research. At any given moment, more than 300 clinical trials are offered throughout the medical center for those difficult to treat cases, in areas such as cancer, neurology, cardiology and other medical specialties. Excellence In Education BIDMCs 1,250 full-time physicians constitute almost a quarter of Harvard Medical School's faculty. Because of our roots, we are committed to training the next generation of doctors, and have raised medical education to a higher level with a uniquely strong and deep program that enhances our ability to attract top faculty and residents. Learning flourishes within our hallways, as students learn from the best of the best in an open environment that produces leaders of tomorrow. Advancing Care in Communities In pursuit of clinical and research excellence, we have formed partnerships with outstanding community hospitals, specialty care centers and physician practice groups in eastern Massachusetts to give you and your family the convenience of high quality care, close to home. With BIDMC at the core of this network, access to specialty care downtown is always available when appropriate. We are dedicated to providing the right care, at the right time, in the right place. Blending Warmth and Innovation Compassionate nursing is central to your experience here. Our nurses are highly regarded for superb care, kindness and proficiency. Our quality and safety initiatives, second to none, are often held up as a model for other institutions. As a hospital deemed "Most Wired," and "Most Wireless," we are reengineering how to gather, safeguard and utilize health information. Our systems are state-of-the-art and all BIDMC clinicians use centrally hosted electronic medical records. The Heart of Caring You expect excellence in clinical care, research, education and community outreach from a prominent academic medical center. But we believe what makes BIDMC even more remarkable is our spirit. We treat our patients with the utmost respect and compassion, as we would our own family members and friends.

Transactions
Details Hidden

CyVek, Inc. raised money in a private placement transaction

Details Hidden

CyVek, Inc. raised money in a private placement transaction

Details Hidden

CyVek, Inc. raised money in a private placement transaction

Investments
Details Hidden

Cybrexa, Inc. develops molecule DNA repair inhibitors that directly target the tumor microenvironment. It develops and commercializes technologies that enables to improve cancer therapeutics. The company was founded by Per J. Hellsund, F. Kevin Didden, Ranjit S. Bindra, and Peter Glazer in 2016 and is headquartered in New Haven, CT.

Details Hidden

CyVek, Inc. engages in the development of a novel, platform technology for measuring analytes in biological samples. It is a biotechnology company dedicated to the advancement of healthcare by empowering researchers and clinicians with a disruptive technology for performing multi-analyte immunoassays. The firm is a versatile platform that can be quickly and easily configured for diverse applications such as rapid diagnostic tests, multi-sample multi-analyte tests, or routine ELISA-like tests, for use in both research and clinical settings. The company offers an breadth of applications, from life science research to drug discovery, personalized medicine, diagnostics, and point-of-care testing. CyVek was founded by Per J. Hellsund, Rajiv Pandey and Marty Andrew Putnam in 2010 and is headquartered in Wallingford, CT.

Other Affiliations

Per J. Hellsund is affiliated with Cybrexa, Inc., CyVek, Inc., inc.jet, Inc., Gunther International Ltd.

This web site is not endorsed by, directly affiliated with, maintained, authorized, or sponsored by Per J. Hellsund. The use of any trade name or trademark is for identification and reference purposes only and does not imply any association with the trademark holder. The Presence of Per J. Hellsund's profile does not indicate a business or promotional relationship of any kind between RelSci and Per J. Hellsund.